Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension

Autor: Guillén-Del-Castillo, Alfredo, Meseguer, Manuel López, Fonollosa-Pla, Vicent, Sáez Giménez, Berta, Colunga-Argüelles, Dolores, Revilla-López, Eva, Rubio-Rivas, Manuel, Ropero, Maria José Cristo, Argibay, Ana, Barberá, Joan Albert, Pla Salas, Xavier, Martínez Meñaca, Amaya, Madroñero Vuelta, Ana Belén, Lara Padrón, Antonio, Sáez Comet, Luis, Domingo Morera, Juan Antonio, González-Echávarri, Cristina, Mombiela, Teresa, Ortego-Centeno, Norberto, Marín González, Manuela, Tolosa-Vilella, Carles, Blanco, Isabel, Escribano Subías, Pilar, Simeón-Aznar, Carmen Pilar, Aurtenetxe Pérez, Águeda, Barrios Garrido-Lestache, Elvira, Bedate Díaz, Pedro, Cifrián, José Manuel, Cristo Ropero, Maria Jose, Dos Subirá, Laura, Elías Hernández, Teresa, García Hernández, Francisco José, Carbonell, Juan Gil, Segovia, Ariadna González, Valverde, Tamara Hermida, Baldomero, Idaira Fámara Hernández, Hernández-González, Ignacio, Huertas, Julia Herrero, Palomares, Luis Jara, Arjona, Josefa Jiménez, Padrón, Antonio Lara, Lázaro-Salvador, María, López-Ramón, Marta, López-Reyes, Raquel, González, Manuela Marín, Meñaca, Amaya Martínez, Etxaniz, Francisco Javier Mazo, Velasco, Virginia Naranjo, Candelera, Remedios Otero, González, Isabel Otero, Lozano, Beatriz Rodríguez, Nieto, María Jesús Rodríguez, Soriano, Joaquín Rueda, Giménez, Berta Sáez, Safont, Belén, Llinas, Ernest Sala, Sebastián, Laura, Cubero, Javier Segovia, Domenech, María Teresa Subirana, Masmiquel, Maria Baldà, Moraga, Eduardo Callejas, Chamorro, Antonio-J., Freire, Mayka, Guillén-del-Castillo, Alfredo, Marín, Maria Teresa Herranz, Vuelta, Ana Belén Madroñero, Ballvé, Adela Marín, Fernández, Melany Pestaña, Salas, Xavier Pla, Pintó, Ignasi Rodríguez, Comet, Luis Sáez, Cervelló, Gonzalo Salvador, Parra, José Antonio Todolí, Trapiella, Luis, Hitos, José Antonio Vargas, Marín, Adela (REHAP Consortium)

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Scientia
Dipòsit Digital de la UB
Universidad de Barcelona

To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from the Spani

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5958a42c72a1e6b39625928ff5294b
https://ddd.uab.cat/record/258149

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.

Autor: Guillén-Del-Castillo A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Meseguer ML; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. manuelop@vhebron.net., Fonollosa-Pla V; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Giménez BS; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.; Physiology Department, Universitat Autònoma de Barcelona, Barcelona, Spain., Colunga-Argüelles D; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain., Revilla-López E; Pneumology Department, Hospital Universitario Vall d'Hebrón, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain., Rubio-Rivas M; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Ropero MJC; Pulmonary Hypertension Unit, Cardiology Department of Hospital, Universitario, 12 de Octubre, Madrid, Spain., Argibay A; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain., Barberá JA; Pulmonary Medicine Department, Hospital Clínic de Barcelona/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Salas XP; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona, Spain., Meñaca AM; Pneumology Department, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain., Vuelta ABM; Department of Internal Medicine, Hospital General San Jorge, Huesca, Spain., Padrón AL; Cardiology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain., Comet LS; Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain., Morera JAD; Pneumology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., González-Echávarri C; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain., Mombiela T; Cardiology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Ortego-Centeno N; Inst Invest Biosanitaria Ibs Granada, Department of Internal Medicine, Unit of Systemic Autoimmune Diseases, Hospital Universitario San Cecilio, Granada, Spain.; Department of Medicine, Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain., González MM; Pneumology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain., Tolosa-Vilella C; Department of Internal Medicine, Parc Taulí, Hospital Universitario, Sabadell, Barcelona, Spain., Blanco I; Pulmonary Medicine Department, Hospital Clínic de Barcelona/Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Subías PE; Pulmonary Hypertension Unit, Cardiology Department of Hospital, Universitario, 12 de Octubre, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)/Instituto de Salud Carlos III, Madrid, Spain., Simeón-Aznar CP; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Publikováno v: Scientific reports [Sci Rep] 2022 Jul 28; Vol. 12 (1), pp. 12947. Date of Electronic Publication: 2022 Jul 28.

Right Ventricular Postsystolic Strain Curve Morphology before and after Vasodilator Treatment in Idiopathic Pulmonary Arterial Hypertension.

Autor: Rodríguez-Pérez Á; Cardiology Department, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain., Bos L; Cardiology Department, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain., Podzamczer I; Pneumology Department, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain., Meseguer ML; Respiratory Department, Hospital Vall d'Hebron, Barcelona, Spain., Mayos-Pérez M; Pneumology Department, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain.; Sant Pau Biomedical Research Institute (IIB Sant Pau), Barcelona, Spain., Leta R; Cardiology Department, Hospital de la Santa Creu i Sant Pau, UAB, Barcelona, Spain.

Publikováno v: CASE (Philadelphia, Pa.) [CASE (Phila)] 2022 Apr 22; Vol. 6 (5), pp. 228-232. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).

An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.

Autor: Simon MA; Division of Cardiology, Department of Medicine University of California San Francisco California USA., Hanrott K; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Budd DC; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Torres F; UT Southwestern Medical Center Dallas Texas USA., Grünig E; Centre for Pulmonary Hypertension Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital Heidelberg Germany., Escribano-Subias P; CIBER-CV Cardiology Department, Pulmonary Hypertension Unit Hospital Universitario 12 de Octubre Madrid Spain., Meseguer ML; Lung Transplant and Pulmonary Vascular Diseases Department Hospital Universitari Vall d'Hebron Barcelona Spain., Halank M; Department of Internal Medicine I University Hospital Carl Gustav Carus Dresden Germany., Opitz C; Department of Cardiology DRK Kliniken Berlin Germany.; Department of Cardiology, University Heart Center Berlin Charité University Medicine Berlin Germany., Hall DA; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Hewens D; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Powley WM; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Siederer S; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Bayliffe A; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK.; Marengo Therapeutics and Apple Tree Partners Cambridge Massachusetts USA., Lazaar AL; Discovery Medicine, Clinical Pharmacology and Experimental Medicine GlaxoSmithKline plc. Collegeville Pennsylvania USA., Cahn A; Research and Development, Medicines Research Centre GlaxoSmithKline plc. Stevenage UK., Rosenkranz S; Department III of Internal Medicine, Cologne Cardiovascular Research Center (CCRC) Cologne University Heart Center Cologne Germany.

Publikováno v: Pulmonary circulation [Pulm Circ] 2022 Jan 20; Vol. 12 (1), pp. e12024. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).